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Abstract
The phylogeographic population structure of Mycobacterium tuberculosis suggests local adaptation to sympatric human
populations. We hypothesized that HIV infection, which induces immunodeficiency, will alter the sympatric relationship
between M. tuberculosis and its human host. To test this hypothesis, we performed a nine-year nation-wide molecular-
epidemiological study of HIV–infected and HIV–negative patients with tuberculosis (TB) between 2000 and 2008 in
Switzerland. We analyzed 518 TB patients of whom 112 (21.6%) were HIV–infected and 233 (45.0%) were born in Europe. We
found that among European-born TB patients, recent transmission was more likely to occur in sympatric compared to
allopatric host–pathogen combinations (adjusted odds ratio [OR] 7.5, 95% confidence interval [95% CI] 1.21–infinity,
p = 0.03). HIV infection was significantly associated with TB caused by an allopatric (as opposed to sympatric) M. tuberculosis
lineage (OR 7.0, 95% CI 2.5–19.1, p,0.0001). This association remained when adjusting for frequent travelling, contact with
foreigners, age, sex, and country of birth (adjusted OR 5.6, 95% CI 1.5–20.8, p = 0.01). Moreover, it became stronger with
greater immunosuppression as defined by CD4 T-cell depletion and was not the result of increased social mixing in HIV–
infected patients. Our observation was replicated in a second independent panel of 440 M. tuberculosis strains collected
during a population-based study in the Canton of Bern between 1991 and 2011. In summary, these findings support a
model for TB in which the stable relationship between the human host and its locally adapted M. tuberculosis is disrupted by
HIV infection.
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Introduction
Host–pathogen co-evolution plays an important role in the
biology of infectious diseases [1]. Coevolution between interacting
host and pathogen species is difficult to demonstrate formally, but
indirect evidence can be obtained by studying geographical
patterns, which can indicate local adaptation of particular
pathogen variants to geographically matched host variants [2–4].
Local adaptation is often studied using so-called reciprocal
transplant experiments, in which the fitness of locally adapted
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(sympatric) pathogen variants is compared to the performance of
allopatric pathogen variants [2]. Studies in several invertebrate
systems have shown that sympatric pathogens (infection with a
phylogeographically concordant strain) tend to outperform allo-
patric pathogens (infection with a phylogeographically discordant
strain) in the corresponding host variants [1,5–7].
Mycobacterium tuberculosis, the agent causing human tuberculosis
(TB) is an obligate human pathogen, which has been affecting
humankind for millennia [8–13]. Contrary to previous beliefs
linking the origin of TB to animal domestication ,10,000 years
ago [14], more recent data suggest that M. tuberculosis evolved as a
human pathogen in Africa, and might have co-existed with
anatomically modern humans since their origins ,200,000 years
ago [8,10,12,13,15]. Analyses of multiple global strain collections
have shown that M. tuberculosis exhibits a phylogeographic
population structure consisting of six main phylogenetic lineages
associated with different geographic regions and sympatric human
populations [9,11–13,16–20]. Studies in San Francisco, London,
and Montreal have shown that these sympatric host–pathogen
associations persist in cosmopolitan settings, even under a
presumed degree of host and pathogen intermingling [11,18,19].
Moreover, transmission of M. tuberculosis has been shown to occur
more frequently in sympatric host–pathogen combinations com-
pared to allopatric host–pathogen combinations [9]. Taken
together, these observations are consistent with the notion that
the different phylogeographic lineages of M. tuberculosis have
adapted to specific sympatric human populations [21].
Based on the assumption that M. tuberculosis has been coevolving
with humans, and that M. tuberculosis has locally adapted to
sympatric human populations [9], we hypothesized that HIV co-
infection will alter this relationship [22]. Specifically, we postulated
that because HIV induces immune suppression in humans, and
because variation in host immunity will likely play a role in local
adaptation, M. tuberculosis strains will cause disease in HIV–
infected patients, irrespective of their usual sympatric host–
pathogen relationship. To test this hypothesis, we performed a
population-based molecular-epidemiological study of HIV–infect-
ed and HIV–negative TB patients in Switzerland between 2000
and 2008, a country with a long history of immigration [23].
Results
Patient characteristics and phylogeographic distribution
of M. tuberculosis lineages
A total of 518 patients were included in the study, of whom 112
(21.6%) were HIV–infected. Of these 518 patients, 233 (45.0%)
were born in Europe (117 in Switzerland), 131 (25.3%) were born
in sub-Saharan Africa, 48 (9.3%) in South-East Asia, 36 (7.0%) in
the Indian subcontinent, and 24 (4.6%) in Central and South
America. Similar to previous studies [9,18,19], we found an
association between the patient’s place of birth and the particular
M. tuberculosis lineages (Figure 1). Lineage 4 (Euro-American
lineage) was present in all regions, but particularly common in
patients born in Europe and South America. Lineages 5 and 6
(West-African lineages also known as M. africanum [24]) were
exclusively found in patients originating from West Africa,
whereas Lineage 2 (which includes Beijing) and Lineage 1 were
mainly seen in patients originating from the Western Pacific and
East Asian regions. Patient characteristics are summarized in
Table 1.
Because in European-born patients the host–pathogen combi-
nations defined as sympatric (i.e. Lineage 4/Euro-American
lineage in European-born patients) or allopatric (i.e. all other
lineages in European-born patients) have been well established
[9,18,19,25], we focused on this patient group (n = 233) for the
remaining of our analyses.
M. tuberculosis transmission occurs primarily in sympatric
host–pathogen combinations
M. tuberculosis transmission was more likely among patients in a
sympatric host–pathogen relationship compared to patients in an
allopatric host–pathogen relationship (adjusted odds ratio [OR]
7.5, 95% confidence interval [95% CI] 1.2-infinity, p = 0.03,
Table 2). Of note, there was no molecular clustering among
European-born TB patients infected with an allopatric M.
tuberculosis strain. Moreover, we found that only the sympatric
Lineage 4 (Euro-American lineage) was detected in European-
born clusters as well as in mixed clusters (Table S1), suggesting that
sympatric host–pathogen combinations in TB favor transmission.
Impact of HIV infection on the sympatric host–pathogen
combination of M. tuberculosis among Europeans
Overall, we found that HIV infection was strongly associated
with allopatric M. tuberculosis lineages among European-born TB
patients (unadjusted OR 7.0, 95% CI 2.5–19.1, p,0.0001;
Table 3). Among the allopatric lineages, we found that Lineages
1, 2 and 3 were more likely to be found in HIV–infected compared
to HIV–negative patients when taking the sympatric Lineage 4
(Euro-American lineage) as the reference (Table S2). When
investigating the ancestry of the nine HIV–infected patients with
an allopatric M. tuberculosis strain, seven patients were confirmed to
be of Swiss ancestry over the last three generations, and two
patients had Swiss and Italian ancestors in the previous
generations (Italian father in the previous generation, or emigrat-
ing from Italy in the previous generation).
Several factors could contribute to the association between HIV
infection and allopatric lineages. We found that patients with an
allopatric M. tuberculosis lineage were younger (median age 41.5
versus 50 years), and had more often a history of frequent
Author Summary
Human tuberculosis (TB) caused by Mycobacterium tuber-
culosis kills 1.5 million people each year. M. tuberculosis has
been affecting humans for millennia, suggesting that
different strain lineages may be adapted to specific human
populations. The combination of a particular strain lineage
and its corresponding patient population can be classified
as sympatric (e.g. Euro-American lineage in Europeans) or
allopatric (e.g. East-Asian lineage in Europeans). We
hypothesized that infection with the human immunode-
ficiency virus (HIV), which impairs the human immune
system, will interfere with this host–pathogen relationship.
We performed a nation-wide molecular-epidemiological
study of HIV–infected and HIV–negative TB patients
between 2000 and 2008 in Switzerland. We found that
HIV infection was associated with the less adapted
allopatric lineages among patients born in Europe, and
this was not explained by social or other patient factors
such as increased social mixing in HIV–infected individuals.
Strikingly, the association between HIV infection and less
adapted M. tuberculosis lineages was stronger in patients
with more pronounced immunodeficiency. Our observa-
tion was replicated in a second independent panel of M.
tuberculosis strains collected during a population-based
study in the Canton of Bern. In summary, our study
provides evidence that the sympatric host–pathogen
relationship in TB is disrupted by HIV infection.
Host–Pathogen Relationship in Human TB
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Figure 1. Phylogeography of the six main Mycobacterium tuberculosis lineages. A: Phylogenetic tree of the main M. tuberculosis lineages
described in our study based on the neighbor-joining phylogeny across 23 M. tuberculosis complex whole-genome sequences (from Ref. [72]).
Numbers on branches refer to the corresponding number of single nucleotide polymorphisms inferred. B: Distribution of the main phylogenetic M.
tuberculosis lineages among Swiss tuberculosis cases included in the study (n = 518), by geographic origin of the patients. In (A) Mycobacterium
canettii was used as the outgroup. SNPs, single nucleotide polymorphisms. In (B) the sizes of the pie charts correspond to the number of patients
Host–Pathogen Relationship in Human TB
PLOS Genetics | www.plosgenetics.org 3 March 2013 | Volume 9 | Issue 3 | e1003318
travelling (38.9% versus 4.2%, p,0.0001). Therefore, we developed
a model (Figure 2) to take these and other putative confounding
variables into account. These variables included age, sex, country of
birth, frequent travelling, contact with the foreign-born population,
and non–HIV associated immunosuppression. We considered ‘‘TB
with an allopatric strain’’ as the outcome because disease is the only
measurable outcome with a sympatric or allopatric M. tuberculosis
strain (only diseased individuals can yield a positive mycobacterial
culture). Our multivariate analyses revealed that the association
between HIV infection and allopatry remained statistically signif-
icant after adjustment for all social and patient factors included in
our model (OR 5.5, 95% CI 1.5–20.6, p = 0.01, Table 3). Age, sex,
being Swiss-born, and non–HIV associated immunosuppression
had only a minor effect on the association between HIV infection
and TB with an allopatric strain (Table 3). In contrast, a history of
repeated travelling to low-income countries had a stronger effect,
decreasing the OR to 4.50 (95% CI 1.5–13.6, p = 0.008, Table 3)
when adjusting for this variable.
Impact of HIV infection on the sympatric host–pathogen
association is a function of the degree of HIV–induced
immunosuppression
We also tested if the degree of immunodeficiency as measured
by the nadir CD4 T cell count (defined as the lowest CD4 T cell
count ever measured in a patient) would have an impact on the
association between host population and M. tuberculosis lineage.
Among Europeans, the strength of the association between HIV
infection and allopatric lineages increased with a decreasing nadir
CD4 T cell count in a dose-dependent manner: from an OR of 4.6
(95% CI 0.9–24.7) in patients with a nadir CD4 T cell count of
.200 cells/mL to an OR of 12.5 (95% CI 2.6–60.8) in patients
with nadir CD4 T cell counts ,50 cells/mL (test for trend
p,0.0001; HIV–negative patients as reference). This trend
remained statistically significant when adjusting for age, sex, being
born in Switzerland, frequent travelling, contact with the foreign-
born population, and non–HIV associated immunosuppression
(Table 4).
Impact of social mixing on the sympatric host–pathogen
association
Increased contact with foreigners originating from high TB
burden countries, who have a higher risk of TB [26] and are more
likely to have TB caused by an allopatric M. tuberculosis strain,
could also lead to an allopatric host–pathogen relationship in
European-born patients. However, the association between HIV
and allopatry remained statistically significant when adjusting for
this variable (Table 3). Furthermore, we examined molecular
clusters defined by standard bacterial genotyping [27,28], to test
included in the study: European region (233 patients), Middle-East/North Africa (27), Indian subcontinent (36), Western Pacific (19), Central/South
America (24), South-East Asia (48), and Eastern (55), Western (46) and Southern region (30) of sub-Saharan Africa. Lineage 1: Indo-Oceanic lineage;
Lineage 2: East-Asian lineage (includes Beijing strains); Lineage 3: Delhi/CAS; Lineage 4: Euro-American lineage; Lineages 5 and 6: West African
lineages.
doi:10.1371/journal.pgen.1003318.g001
Table 1. Patient characteristics of tuberculosis (TB) patients born in Europe, by presence of allopatric and sympatric
Mycobacterium tuberculosis strains.
Characteristic All Allopatric Sympatric P value
(n =233) (n =18) (n =215)
Age, median (IQR), years 49 (36–71) 41.5 (32–45) 50 (37–73) 0.0029
Male sex, n (%) 126 (54.1) 10 (55.6) 116 (54.0) 0.90
Origin of birth, n (%) 0.46
Switzerland 118 (50.6) 11 (61.1) 107 (49.9)
Europe (without Switzerland) 115 (49.4) 7 (38.9) 108 (50.2)
Cavitary disease, n (%) 55 (23.6) 4 (22.2) 51 (23.7) 0.991
Clinical manifestation, n (%) 0.541
Pulmonary 191 (82.0) 16 (88.9) 175 (81.4)
Extrapulmonary 42 (18.0) 2 (11.1) 40 (18.6)
Recent TB within families/social surroundings 15 (6.4) 0 (0) 15 (7.0) 0.611
Frequent travelling 16 (6.9) 7 (38.9) 9 (4.2) ,0.00011
HIV infection, n (%) 36 (15.5) 9 (50.0) 27 (12.6) ,0.00011
Immunosuppression other than HIV infection2, n (%) 24 (10.3) 1 (5.6) 23 (10.7) 0.70
Most likely source of HIV infection3, n (%) 0.941
Heterosexual 15 (41.7) 5 (55.6) 10 (37.0)
Injecting drug user 9 (25.0) 2 (22.2) 7 (25.9)
Men having sex with men 7 (19.4) 2 (22.2) 5 (18.5)
Others/unknown 5 (13.9) 0 (0) 5 (18.5)
1Fisher’s exact test.
2Use of TNF-alpha inhibitors, malignancy, organ transplantation, use of steroids, or methotrexate.
3Among HIV–infected patients (n = 36).
95% CI, 95% confidence interval; IQR, interquartile range.
doi:10.1371/journal.pgen.1003318.t001
Host–Pathogen Relationship in Human TB
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the hypothesis that HIV–infected patients were more frequently
seen among ethnically mixed clusters where transmission occurred
between non-European and European-born cases [29]. We found
that the prevalence of HIV infection was similar among TB cases
in mixed clusters (5 HIV–infected cases out of 26 cases, 19.2%)
and among cases in clusters involving only European-born cases (4
out of 26 cases, 15.4%, see Table S1).
Sensitivity analyses
When restricting the main analysis (n = 233) to European-born
patients without a history of frequent travelling, we found that the
association between HIV infection and allopatric TB remained
statistically significant (adjusted OR 6.96, 95% CI 1.25–38.88,
p = 0.027). Furthermore, we explored associations of socio-demo-
graphic and clinical factors with TB with an allopatric M. tuberculosis
strain in a model focusing on HIV–infected European patients only
(Figure S1, Table S3): frequent travelling was confirmed to be an
important factor, and patients with a low nadir CD4 T cell count
tended to be associated with an allopatric TB although the associations
did not reach statistical significance (Table S3). Finally, we obtained
very similar results for the association between HIV infection and
allopatric TB (Table S4), and for the association between the degree of
immunodeficiency and allopatric TB (Table S5) when repeating
analyses using a Bayesian approach [30], which is more robust when
numbers are small.
Other supporting information
The birth origin of HIV–infected and non-infected patients is
shown on a map in Figure S2. The main phylogenetic M.
tuberculosis lineages stratified by place of birth and HIV status are
presented in Table S6.
Replication in a second panel of M. tuberculosis strains
To replicate our main finding, we investigated a second panel
of M. tuberculosis strains from an ongoing population-based TB
study in the Canton of Bern, Switzerland, between 1991 and
2011. Of the 1,642 M. tuberculosis isolates analyzed, 1,350
(82.2%) belonged to Lineage 4 (Euro-American lineage), and
292 (17.8%) to non-Euro-American lineages (Lineages 1, 2, 3, 5
or 6). We compared all 40 European-born patients with an
allopatric strain (non-Lineage 4) with 400 randomly selected
European-born patients with a sympatric strain (Lineage 4). We
found that the proportion of HIV infection was 4.5 (95% CI
1.6–11.9) times higher in patients with an allopatric strain
compared to patients with a sympatric strain (12.5% versus
2.8%, p = 0.010, Table 5).
Table 2. Recent transmission of Mycobacterium tuberculosis among tuberculosis (TB) cases born in the European region, according
to sympatric and allopatric lineages.
Lineages n (%) cases Association of transmission with lineages
Clustered Unclustered P value1 OR (95% CI) P value Adjusted OR (95% CI) P value
0.024 0.048 0.027
Sympatric 42 (19.5) 173 (80.5) 6.09 (1.01-‘) 7.48 (1.21-‘)
Allopatric 0 (0) 18 (100) 1 (Ref) - 1 (Ref) -
Recent transmission was determined by spoligotyping and MIRU-VNTR genotyping which is based on repetitive sequences. Clustered cases were defined as cases
belonging to a molecular cluster of TB transmission based on isolates showing an identical genotyping pattern, and unclustered as cases with a unique genotyping
pattern. Sympatric was defined as a strain belonging to Lineage 4 (Euro-American lineage), allopatric as a strain belonging to a lineage other than Lineage 4.
1Fisher’s exact test (1-sided).
95% CI, 95% confidence interval; ND, not defined; OR, Odds Ratio.
Odds ratios were derived from exact logistic models. Model was adjusted for age group (45 years and younger), being born in Switzerland and recent TB in families or
social surroundings.
doi:10.1371/journal.pgen.1003318.t002
Table 3. Unadjusted and adjusted associations between HIV infection and tuberculosis (TB) with an allopatric Mycobacterium
tuberculosis strain among European patients (n = 233), in the context of other potential factors influencing the risk for an allopatric
TB.
Variables adjusted for1 OR (95% CI) P value
Unadjusted 6.96 (2.54–19.08) ,0.0001
Age, sex, Swiss-born 7.54 (2.32–24.55) 0.0010
Frequent travelling 4.50 (1.49–13.61) 0.0080
Age, sex, Swiss-Born, frequent travelling, contact with foreign-born population 5.57 (1.49–20.81) 0.011
Immunosuppression2 7.06 (2.57–19.42) ,0.0001
Age, sex, Swiss-born, frequent travelling, contact with foreign-born population,
immunosuppression2
5.51 (1.47–20.61) 0.011
HIV–negative TB patients were used as the reference group.
1See Figure 2 for a graphical overview of associations.
2Immunosuppression other than HIV infection (use of anti-TNF blockers, malignancy, organ transplantation, use of steroids or methotrexate).
OR, odds ratio; 95% CI, 95% confidence interval.
doi:10.1371/journal.pgen.1003318.t003
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Discussion
The phylogeographic distribution of M. tuberculosis lineages
observed here suggests local adaptation to sympatric human
populations. In contrast, we found that allopatric host–pathogen
relationships in European-born TB patients were strongly associ-
ated with HIV co-infection. The association with HIV infection
became stronger in a ‘dose-dependent’ manner in patients with a
history of more pronounced immunodeficiency, and was not
explained only by frequent travelling to high TB-incidence
countries or increased social mixing with the foreign-born
population. The association of M. tuberculosis lineages with sympatric
patient populations reported here is in agreement with previous
findings [9,11–13,16–19]. Similarly, our finding that recent TB
transmission was more likely to occur in sympatric compared to
allopatric host–pathogen combinations supports previous work [9].
Taken together, these data are consistent with local adaptation of
M. tuberculosis to different human populations, which in turn can be
viewed as indirect evidence for coevolution between M. tuberculosis
and its human host [1–4,9–13].
Figure 2. Graphical model showing direct and indirect potential effects of HIV infection on tuberculosis (TB) caused by an allopatric
Mycobacterium tuberculosis strain, in the context of other potential factors influencing this association.
doi:10.1371/journal.pgen.1003318.g002
Table 4. Association between the degree of immunodeficiency and tuberculosis with an allopatric Mycobacterium tuberculosis
strain among European patients (n = 233).
Degree of immunodeficiency n Unadjusted Adjusted
OR 95% OR P value OR 95% OR P value
Nadir CD4 T cell count (CD4 cells/ml) ,0.0001 0.0050
HIV–negative 197 1.0 (ref) 1.0 (ref)
$200 11 4.64 (0.87–24.70) 2.56 (0.37–17.65)
50–199 17 6.43 (1.74–23.70) 6.96 (1.18–41.11)
,50 8 12.53 (2.58–60.84) 13.0 (1.54–109.75)
Model was adjusted for age, sex, Swiss-born, frequent travelling, contact with foreign-born population, and immunosuppression other than HIV infection (see Figure 2
for a graphical overview).
P values of linear tests for trend are shown.
doi:10.1371/journal.pgen.1003318.t004
Host–Pathogen Relationship in Human TB
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We found that TB allopatric host–pathogen combinations were
strongly associated with HIV infection in a nation-wide study and
a second panel of strains from one Canton of Switzerland. This
supports the notion that M. tuberculosis lineages have evolved subtle
differences in their interaction with different human immune
systems. However, in the presence of HIV–induced immunode-
ficiency, any M. tuberculosis lineage seems to cause disease in a given
human host. M. tuberculosis is an obligate human pathogen which
lives in constant interaction with the host immune system [31].
Human populations, however, are known to differ genetically and
immunologically [15]. The clinical disease reflects host-dependent
immune-pathological processes [31]. In other words, while initially
triggered by the pathogen, it is the host immune response which is
ultimately responsible for the chronic inflammation and associated
tissue destructions. These processes contribute to the successful
transmission of M. tuberculosis [22,32]. On the other hand, only 5–
10% of the 2 billion individuals estimated to be latently infected
with M. tuberculosis globally will develop active TB during their
lifetime [33–35]. Hence most of the time, humans are able to
control the infection. In our study, we chose culture-confirmed TB
cases as the main endpoint which reflects successful transmission
and progression from infection to active disease.
Our study on the association between allopatric TB and HIV
was able to control for important cofactors [36,37]. These
cofactors included frequent travelling abroad and increased
contact to foreign-born populations. A particularly important
cofactor for allopatric TB was frequent travelling to high TB
burden countries with potential exposure to foreign M. tuberculosis
strains; HIV–infected individuals may be at a higher risk for travel-
related infectious diseases [38]. However, the association between
HIV infection and allopatric TB remained even when adjusting
for these behavioral and other patient characteristics. A previous
study reporting on allopatric TB and HIV was not able to control
for these factors [9]. Furthermore, we found no evidence for
increased social mixing among HIV–infected individuals, which
argues against mere social factors leading to the association
between allopatric TB and HIV.
A biological basis for this association is further supported by the
striking dose-dependency we observed with increasing immuno-
suppression as defined by lower nadir CD4 T cell counts. Of note,
this trend was also independent of other variables. Low nadir CD4
T cell counts are associated with incomplete immune recovery after
starting combination antiretroviral therapy [39,40] and impaired
functional immune restoration despite normalization of CD4 T cells
[41]. More generally, infection with HIV and M. tuberculosis
interferes with the immune system in many ways [42,43]. HIV
infection disrupts the function of M. tuberculosis-infected macro-
phages [44,45], but also seems to reduce the number and
functionality of M. tuberculosis-specific T cells over time [46]. On
the other hand, M. tuberculosis strains have been shown to induce
variable immune responses [47]. Based on these observations, it is
reasonable to hypothesize that HIV/TB co-infection might impact
immune cell functions, intracellular signaling and immune regula-
tion, perhaps leading to an immune response less capable of
discriminating between M. tuberculosis variants.
Besides M. tuberculosis, several other human pathogenic bacteria
exhibit phylogeographic population structures, possibly reflecting
local adaptation to different human populations. These include
Haemophilus influenzae [48], Streptococcus mutans [49], M. leprae [50] and
Helicobacter pylori [51,52]. Interestingly, like M. tuberculosis, all of these
microbes are obligate human pathogens. In the case of H. pylori,
functional studies have shown that strains associated with South
America have adapted their adhesins to the human blood group O,
which is particularly frequent in native populations of this region
[53]. Similarly, a study of the bacterial genome evolution of an
asymptomatic Escherichia coli bacteriuria strain showed adaptation at
the genomic level in distinct human hosts [54]. No similar
experimental work has yet been carried out in TB. However,
several studies have reported associations between human genetic
polymorphisms and particular M. tuberculosis lineages [55–59],
indicating possible interaction between human and M. tuberculosis
variation. Whether such variation in pathogen and host genetics can
be attributed to co-evolution will be difficult to demonstrate
conclusively, but the data presented here support this possibility.
The strength of our study was that we used a nation-wide sample
to specifically look at the impact of HIV infection on the host–
pathogen relationship in human TB. Yet, our study is limited by the
relatively small sample size, and the difficulty to quantify the
complex social context through which the host–pathogen relation-
ship is influenced in human TB. In addition, we looked at European-
born patients only, because sympatric and allopatric host–pathogen
combinations are more easily defined for this patient population
[9,18,19,25]. Additional studies in large cosmopolitan cities of Asia
and Africa would be required to test whether the association between
allopatric TB and HIV holds true in these settings. Ultimately,
detailed experimental work is needed to establish the biological basis
of the host–pathogen association in human TB.
In conclusion, our data suggest that the phylogeographical host–
pathogen relationship in TB influences transmission patterns. Among
the studied European-born TB patients, we showed that HIV
infection disrupts the sympatric host–pathogen relationship in human
TB, and that this effect increased as a function of immunodeficiency.
Various interactions between HIV and M. tuberculosis at the cellular
level make an association biologically plausible [42,43]. Further
studies are needed to investigate the impact of HIV on the genetic
population structure of M. tuberculosis with its consequences for
transmission and clinical manifestations in high TB burden countries
[36]. This will lead to a better understanding of biological factors that
shape the current HIV/TB syndemic [60].
Methods
Study setting
The Swiss Molecular Epidemiology of Tuberculosis (SMET)
study is a collaborative project between the Swiss HIV Cohort
Table 5. HIV status in tuberculosis (TB) patients with an
allopatric compared to patients with a sympatric
Mycobacterium tuberculosis strain among European patients in
a second panel.
HIV status TB cases, n (%) P value
All
(n = 440)
Allopatric
(n = 40)
Sympatric
(n = 400)
0.0101
HIV–infected 16 (3.6) 5 (12.5) 11 (2.7)
HIV–negative 424 (96.4) 35 (87.5) 389 (97.3)
Prevalence
ratio (95% CI)
4.55
(1.66–12.43)
Patient isolates were obtained from a population-based TB study (n = 1,642) in
the Canton of Bern, Switzerland, diagnosed between 1991 and 2011.
Sympatric was defined as a strain belonging to Lineage 4 (Euro-American
lineage), allopatric as a strain belonging to a lineage other than Lineage 4.
1Fisher’s exact test.
95% CI, 95% confidence interval.
doi:10.1371/journal.pgen.1003318.t005
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Study (SHCS), the National Center for Mycobacteria, diagnostic
microbiology laboratories, departments of respiratory medicine
and public health, and the Federal Office of Public Health (FOPH)
[29,61,62]. The overarching aims were to examine the genetic
population structure of M. tuberculosis and the associations between
strain variation, patient origin, and clinical characteristics in HIV–
infected and HIV–negative TB patients in Switzerland. Further
information on the SMET project is available at www.tb-network.
ch. All participating sites are listed in the Acknowledgements.
The SHCS is a prospective observational study of HIV–infected
individuals followed up in HIV outpatient clinics in Switzerland
[63]. All HIV–infected patients diagnosed with TB between 2000
and 2008 whose M. tuberculosis complex (MTBC) isolate was
available were included in the SMET study [29]. Furthermore, we
randomly selected 288 from the 4,221 culture-confirmed TB cases
reported to the National TB Surveillance Registry during the same
period (approximately three cases for one HIV–infected TB case
within the SHCS). Finally, all reported drug-resistant TB cases
were included. Two M. bovis isolates were excluded from this study
as they are animal-adapted species within the MTBC and
therefore represent a different host–pathogen relationship.
Clinical data collection and definitions
We obtained clinical data by standardized questionnaires sent to
the treating physicians and extracted relevant data from the SHCS
database. We collected socio-demographic data (age, sex, origin of
birth, citizenship, legal status, immunosuppressive therapy, risk
factors for TB such as recent TB within family or immediate social
surroundings in the last two years), laboratory parameters (CD4
cell count and plasma HIV RNA in HIV–infected cases) and
clinical information (site of disease, radiography findings). Chest
radiography parameters were consolidation, cavitations, enlarged
intrathoracic lymph nodes and pleural thickening. Any drug
resistance was defined as any resistance to isoniazid, rifampicin or
ethambutol as reported to the FOPH. Most TB cases in
Switzerland are treated under the guidance of experienced
infectious and respiratory disease specialists, and the clinical data
were of high quality.
Geographic origin of patients was defined as the country of
birth, and countries were grouped in seven geographic regions (see
Figure 1) according to the current understanding of the
phylogeography of M. tuberculosis [25]. Birth country was used as
a proxy of the ancestry of the study population. Immunosuppres-
sion due to other causes than HIV infection was defined as use of
TNF-alpha inhibitors, malignancy, solid organ transplantation,
use of steroids or methotrexate. Nadir CD4 T cell count was
defined as the lowest CD4 T cell count (cells/mL) ever measured in
a patient. Nadir CD4 T cell count is a predictor of poor immune
recovery after ART [39]. Travel history was extracted from the
free text field ‘‘Risk factor for TB’’ and defined as repeated
travelling of longer duration (.30 days) to low-income countries
with a high TB burden and a relevant exposure to M. tuberculosis
according to the physician’s judgment. Belonging to a molecular
cluster involving Swiss-born and foreign-born TB cases was used
as a proxy for contact with the foreign-born population.
Molecular analyses
Mycobacterial isolates were cultured and DNA extracted
according to standard laboratory procedures. We used spacer
oligonucleotide typing (spoligotyping) and 24-loci mycobacterial
interspersed repetitive units (MIRU-VNTR) which are based on
repetitive DNA sequences as genotyping tools with high discrim-
inatory power to identify recent TB transmission [29,64–66]. Data
were analyzed with the MIRU-VNTRplus online tool (http://
www.miru-vntrplus.org). Molecular clusters were defined as a
group of completely identical isolates in the spoligotyping and
MIRU-VNTR pattern indicating a chain of TB transmission. In
addition, we used single nucleotide polymorphisms (SNPs) as
stable genetic markers to define the main phylogenetic M.
tuberculosis lineages [67]. Lineages were determined by SNPs using
multiplex real-time PCR with fluorescence-labeled probes (Taq-
man, Applied Biosystems, USA) adopted from previous studies
[9,12,67,68]. The SNP used to define Lineage 4 was originally
described by Sreevatsan et al. [69] and shown to be specific to this
lineage [9].
Graphical models
Graphical models were built using the principles of directed
acyclic graphs [70]. Our model considered infection and disease as
a combined outcome (‘‘TB with an allopatric strain’’). Our
hypothesis that HIV infection causes TB with an allopatric strain is
shown as a potentially causal direct effect, and risk factors
potentially influencing this effect are shown in the hypothetical
direction. Mediators represent variables that are caused by the
independent variable and, in turn, have a direct effect on the
outcome variable. We included age and sex in our model as risk
factors for infection and disease [37]. We also considered contact
with the foreign-born population who have a higher risk for TB
compared to the native Swiss population [26] and who have a
higher risk of exposure to ‘‘foreign’’ M. tuberculosis strains. Finally,
we included frequent traveling to countries with a high TB
burden, which increases exposure risk and thus potentially
infection risk with ‘‘foreign’’ M. tuberculosis strains (Figure 2).
Statistical analyses
We used x2 tests or Fisher’s exact tests to assess differences
between groups in binary variables, and the Wilcoxon rank sum
test for continuous variables (Table 1, Table 2). Univariate and
multivariate exact logistic regression models were fitted to estimate
the association between transmission as defined by molecular
clustering and patients with sympatric M. tuberculosis lineages
(patients with allopatric lineages were used as the reference,
Table 2). Results were presented as ORs unadjusted and adjusted
for age group, being born in Switzerland and recent TB in families
or social surroundings. To assess the association of HIV infection
with allopatric TB, we fitted univariate and multivariate logistic
models (Table 3), and presented ORs unadjusted and adjusted for
age, sex, Swiss-born, frequent travelling, contact with foreign born
populations, and/or immunosuppression. We used univariate and
multivariate logistic models to estimate the association between the
degree of immunodeficiency and allopatric TB (Table 4), and
presented ORs unadjusted and adjusted for age, sex, Swiss-born,
frequent travelling, contact with foreign-born populations, and
immunosuppression other than HIV infection. Finally, we
determined statistical significance of HIV prevalence in patients
with allopatric M. tuberculosis lineages compared to patients with
sympatric lineages using Fisher’s exact tests (Table 5). All analyses
were performed in Stata version 11.1 (Stata Corporation, College
Station, TX, USA).
Sensitivity analyses
In sensitivity analyses, we excluded patients with a history of
frequent travelling to remove its influence on the association
between HIV infection and allopatric lineages. In addition, we
repeated the analyses using fully probabilistic Bayesian methods
using weakly informative prior distributions [71]. The CIs
reported from these analyses are 95% credible intervals and
correspond to tail probabilities of the coefficient’s posterior
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distributions. Bayesian statistics are less sensitive to errors when
calculating estimators and CIs in small datasets.
Second panel of M. tuberculosis strains
We obtained 1,642 M. tuberculosis isolates from all TB cases
(n = 1,940, 84.6%) notified in the Canton of Bern, Switzerland,
between 1991 and 2011. For all patient isolates, we determined the
main phylogenetic M. tuberculosis lineages. Of these, we included all
patient isolates belonging to a non-Euro-American lineage
(Lineage 1, 2, 3, 5 or 6) from European-born TB patients (40 of
a total of 292 isolates belonging to lineages other than Lineage 4).
Furthermore, we randomly selected control strains belonging to
the Euro-American lineage (Lineage 4) from European-born TB
patients (400 of a total of 1,350 isolates belonging to Lineage 4).
European ancestry was confirmed in HIV–infected patients with
an allopatric M. tuberculosis strain. Finally, we determined the HIV
status in these patients using the same procedures as in the main
sample.
Ethics approval
The study was approved by the ethics committee of the
Canton of Bern, Switzerland. Written informed consent was
obtained from all patients enrolled in the SHCS. For patients
outside the SHCS, written informed consent was obtained by the
treating physicians. In some cases informed consent could not be
obtained from the patient because he or she could not be located
or was known to have died. For these cases we obtained
permission from the Federal expert commission on confidenti-
ality in medical research to use the data provided by the treating
physician.
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